Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-021947
Filing Date
2021-03-18
Accepted
2021-03-18 20:46:41
Documents
2
Period of Report
2021-03-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 6283
2 POA DOCUMENT poa.txt EX-24.3_974413 3229
  Complete submission text file 0001209191-21-021947.txt   10874
Mailing Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219
Business Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219 (972) 499-3350
Instil Bio, Inc. (Issuer) CIK: 0001789769 (see all company filings)

EIN.: 832072195 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O INSTIL BIO, INC. 3963 MAPLE AVENUE, SUITE 350 DALLAS TX 75219
Business Address
Roberts Zachary (Reporting) CIK: 0001851044 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40215 | Film No.: 21756197